MDWD MediWound Ltd

Price (delayed)

$18.95

Market cap

$174.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.75

Enterprise value

$171.49M

mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe ...

Highlights

The EPS has surged by 81% year-on-year and by 59% since the previous quarter

The net income has soared by 66% YoY and by 46% from the previous quarter

The equity has surged by 189% year-on-year but it has declined by 4.4% since the previous quarter

The company's quick ratio fell by 27% QoQ but it rose by 19% YoY

MediWound's debt has surged by 137% YoY and by 13% QoQ

MDWD's gross profit has dropped by 73% year-on-year and by 68% since the previous quarter

Sector: Healthcare

Industry: Biotechnology

Website: http://www.mediwound.com

Peers: JNJ TEVA

Key stats

What are the main financial stats of MDWD

Market

Shares outstanding

9.22M

Market cap

$174.75M

Enterprise value

$171.49M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

5.53

Price to sales (P/S)

9.14

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

9.18

Earnings

Revenue

$18.69M

EBIT

-$4.64M

EBITDA

-$3.34M

Free cash flow

-$16.93M

Per share

EPS

-$0.75

Free cash flow per share

-$1.88

Book value per share

$3.43

Revenue per share

$2.07

TBVPS

$7.36

Balance sheet

Total assets

$66.46M

Total liabilities

$34.86M

Debt

$8.61M

Equity

$31.6M

Working capital

$38.87M

Liquidity

Debt to equity

0.27

Current ratio

4.59

Quick ratio

4.35

Net debt/EBITDA

0.98

Margins

EBITDA margin

-17.9%

Gross margin

19.1%

Net margin

-35.9%

Operating margin

-81.8%

Efficiency

Return on assets

-10.1%

Return on equity

-20.2%

Return on invested capital

-11.8%

Return on capital employed

-8.3%

Return on sales

-24.8%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

MDWD stock price

How has the MediWound stock price performed over time

Intraday

0.58%

1 week

3.89%

1 month

26.67%

1 year

73.22%

YTD

86.33%

QTD

32.98%

Financial performance

How have MediWound's revenue and profit performed over time

Revenue

$18.69M

Gross profit

$3.58M

Operating income

-$15.29M

Net income

-$6.72M

Gross margin

19.1%

Net margin

-35.9%

The company's operating margin has shrunk by 160% YoY and by 120% QoQ

MDWD's operating income has shrunk by 83% YoY and by 65% QoQ

MDWD's gross profit has dropped by 73% year-on-year and by 68% since the previous quarter

The net income has soared by 66% YoY and by 46% from the previous quarter

Growth

What is MediWound's growth rate over time

Valuation

What is MediWound stock price valuation

P/E

N/A

P/B

5.53

P/S

9.14

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

9.18

The EPS has surged by 81% year-on-year and by 59% since the previous quarter

The equity has surged by 189% year-on-year but it has declined by 4.4% since the previous quarter

MDWD's P/B is 96% above its last 4 quarters average of 2.8 but 57% below its 5-year quarterly average of 12.9

The P/S is 153% higher than the 5-year quarterly average of 3.6 and 116% higher than the last 4 quarters average of 4.2

MediWound's revenue has decreased by 29% YoY and by 25% from the previous quarter

Efficiency

How efficient is MediWound business performance

The return on sales has dropped by 107% since the previous quarter but it has increased by 17% year-on-year

MDWD's ROE has soared by 97% YoY and by 54% QoQ

MDWD's ROIC has soared by 92% year-on-year but it is down by 11% since the previous quarter

The ROA has soared by 84% YoY and by 49% from the previous quarter

Dividends

What is MDWD's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MDWD.

Financial health

How did MediWound financials performed over time

The company's total assets is 91% higher than its total liabilities

The company's total assets rose by 33% YoY

The company's quick ratio fell by 27% QoQ but it rose by 19% YoY

MediWound's debt is 73% lower than its equity

The equity has surged by 189% year-on-year but it has declined by 4.4% since the previous quarter

MediWound's debt has surged by 137% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.